PodParley PodParley
PodParley
VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study - Introduction to VolitionRx Nucleosomics� technology: Revolutionizing cancer diagnosis episode artwork

EPISODE · Oct 22, 2015

VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study - Introduction to VolitionRx Nucleosomics� technology: Revolutionizing cancer diagnosis

from MultiVu Healthcare News

VolitionRx�s Nucleosomics� diagnostic platform detects epigenetic changes to fragments of chromosomes, called nucleosomes, that circulate in the blood of cancer patients. Credit: VolitionRx.

Episode metadata supplied by the publisher feed · Published Oct 22, 2015

Embed this episode

NOW PLAYING

VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study - Introduction to VolitionRx Nucleosomics� technology: Revolutionizing cancer diagnosis

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this MultiVu Healthcare News episode published?

This episode was published on October 22, 2015.

Can I download this MultiVu Healthcare News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!